Medical Care
Global Immune-Mediated Inflammatory Diseases Treatment Market Research Report 2025
- Sep 09, 25
- ID: 494619
- Pages: 80
- Figures: 78
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Immune-Mediated Inflammatory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune-Mediated Inflammatory Diseases Treatment.
The Immune-Mediated Inflammatory Diseases Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune-Mediated Inflammatory Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune-Mediated Inflammatory Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Segment by Type
Targeted biologic therapies
Novel therapies
Segment by Application
Hospitals
Pharmacy Store
Online Pharmacy Stroe
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune-Mediated Inflammatory Diseases Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Immune-Mediated Inflammatory Diseases Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune-Mediated Inflammatory Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune-Mediated Inflammatory Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Segment by Type
Targeted biologic therapies
Novel therapies
Segment by Application
Hospitals
Pharmacy Store
Online Pharmacy Stroe
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune-Mediated Inflammatory Diseases Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted biologic therapies
1.2.3 Novel therapies
1.3 Market by Application
1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Pharmacy Store
1.3.4 Online Pharmacy Stroe
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2020-2031)
2.2 Global Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Region
2.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Region (2020-2025)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2026-2031)
2.3 Immune-Mediated Inflammatory Diseases Treatment Market Dynamics
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Industry Trends
2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2020-2025)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2024
3.5 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment Head office and Area Served
3.6 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Product and Application
3.7 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2020-2025)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2026-2031)
5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2020-2025)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Details
11.4.2 Bristol-Myers Business Overview
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.4.5 Bristol-Myers Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Details
11.7.2 Enlivex Therapeutics Business Overview
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.7.5 Enlivex Therapeutics Recent Development
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Details
11.8.2 Immune Pharmaceuticals Business Overview
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.8.5 Immune Pharmaceuticals Recent Development
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Details
11.9.2 Tanabe Pharma Business Overview
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.9.5 Tanabe Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted biologic therapies
1.2.3 Novel therapies
1.3 Market by Application
1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Pharmacy Store
1.3.4 Online Pharmacy Stroe
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2020-2031)
2.2 Global Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Region
2.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Region (2020-2025)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2026-2031)
2.3 Immune-Mediated Inflammatory Diseases Treatment Market Dynamics
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Industry Trends
2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2020-2025)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2024
3.5 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment Head office and Area Served
3.6 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Product and Application
3.7 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2020-2025)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2026-2031)
5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2020-2025)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)
10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Details
11.4.2 Bristol-Myers Business Overview
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.4.5 Bristol-Myers Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Details
11.7.2 Enlivex Therapeutics Business Overview
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.7.5 Enlivex Therapeutics Recent Development
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Details
11.8.2 Immune Pharmaceuticals Business Overview
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.8.5 Immune Pharmaceuticals Recent Development
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Details
11.9.2 Tanabe Pharma Business Overview
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
11.9.5 Tanabe Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeted biologic therapies
Table 3. Key Players of Novel therapies
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2020-2025)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2026-2031)
Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends
Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2020-2025)
Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2024)
Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Headquarters and Area Served
Table 20. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Product and Application
Table 21. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. GlaxoSmithKline Company Details
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product
Table 49. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Eli Lilly Company Details
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product
Table 54. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. AstraZeneca Company Details
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product
Table 59. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Bristol-Myers Company Details
Table 62. Bristol-Myers Business Overview
Table 63. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product
Table 64. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 65. Bristol-Myers Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product
Table 69. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Immune-Mediated Inflammatory Diseases Treatment Product
Table 74. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Enlivex Therapeutics Company Details
Table 77. Enlivex Therapeutics Business Overview
Table 78. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product
Table 79. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 80. Enlivex Therapeutics Recent Development
Table 81. Immune Pharmaceuticals Company Details
Table 82. Immune Pharmaceuticals Business Overview
Table 83. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product
Table 84. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 85. Immune Pharmaceuticals Recent Development
Table 86. Tanabe Pharma Company Details
Table 87. Tanabe Pharma Business Overview
Table 88. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product
Table 89. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 90. Tanabe Pharma Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. Immune-Mediated Inflammatory Diseases Treatment Picture
Figure 2. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2024 VS 2031
Figure 4. Targeted biologic therapies Features
Figure 5. Novel therapies Features
Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Pharmacy Store Case Studies
Figure 10. Online Pharmacy Stroe Case Studies
Figure 11. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2024
Figure 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2024
Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 20. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 24. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2020-2031)
Figure 32. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 48. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 49. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 50. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 53. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 54. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 55. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeted biologic therapies
Table 3. Key Players of Novel therapies
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2020-2025)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2026-2031)
Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends
Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2020-2025)
Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2024)
Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Headquarters and Area Served
Table 20. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Product and Application
Table 21. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. GlaxoSmithKline Company Details
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product
Table 49. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Eli Lilly Company Details
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product
Table 54. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. AstraZeneca Company Details
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product
Table 59. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Bristol-Myers Company Details
Table 62. Bristol-Myers Business Overview
Table 63. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product
Table 64. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 65. Bristol-Myers Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product
Table 69. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Immune-Mediated Inflammatory Diseases Treatment Product
Table 74. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Enlivex Therapeutics Company Details
Table 77. Enlivex Therapeutics Business Overview
Table 78. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product
Table 79. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 80. Enlivex Therapeutics Recent Development
Table 81. Immune Pharmaceuticals Company Details
Table 82. Immune Pharmaceuticals Business Overview
Table 83. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product
Table 84. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 85. Immune Pharmaceuticals Recent Development
Table 86. Tanabe Pharma Company Details
Table 87. Tanabe Pharma Business Overview
Table 88. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product
Table 89. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)
Table 90. Tanabe Pharma Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. Immune-Mediated Inflammatory Diseases Treatment Picture
Figure 2. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2024 VS 2031
Figure 4. Targeted biologic therapies Features
Figure 5. Novel therapies Features
Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Pharmacy Store Case Studies
Figure 10. Online Pharmacy Stroe Case Studies
Figure 11. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2024
Figure 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2024
Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 20. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 24. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2020-2031)
Figure 32. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 48. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 49. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 50. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 51. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 53. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 54. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 55. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232